Roth Capital Forecasts OTC:GTBIF FY2024 Earnings

Green Thumb Industries Inc. (OTC:GTBIF) – Analysts at Roth Capital issued their FY2024 EPS estimates for Green Thumb Industries in a research report issued to clients and investors on Sunday, November 10th. Roth Capital analyst W. Kirk forecasts that the company will post earnings per share of $0.32 for the year. Roth Capital has a “Strong-Buy” rating on the stock. The consensus estimate for Green Thumb Industries’ current full-year earnings is $0.32 per share. Roth Capital also issued estimates for Green Thumb Industries’ Q4 2024 earnings at $0.07 EPS, Q1 2025 earnings at $0.07 EPS, Q2 2025 earnings at $0.08 EPS, Q3 2025 earnings at $0.07 EPS, Q4 2025 earnings at $0.08 EPS and FY2025 earnings at $0.30 EPS.

A number of other equities analysts have also recently weighed in on GTBIF. Ventum Cap Mkts raised shares of Green Thumb Industries to a “strong-buy” rating in a research report on Tuesday, August 6th. Craig Hallum upgraded shares of Green Thumb Industries to a “strong-buy” rating in a report on Monday, September 16th.

Green Thumb Industries Trading Up 8.4 %

Shares of OTC GTBIF opened at $9.70 on Wednesday. The stock’s fifty day moving average price is $10.24. The company has a market capitalization of $2.05 billion, a PE ratio of 35.93 and a beta of 1.40. Green Thumb Industries has a twelve month low of $7.50 and a twelve month high of $16.33.

Green Thumb Industries Company Profile

Green Thumb Industries Inc manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon’s, Good Green, incredibles, and RHYTHM brands.